Ubiquigent and University of Glasgow to collaborate on drug discovery
Ubiquigent Limited, a drug discovery and development company harnessing novel deubiquitinase (DUB) modulators as new…
January 24, 2023 - 3 minutes
Neurodegenerative disease
JPND launches €16.5M call for research on OMICS data for neurodegenerative diseases
The EU Joint Programme – Neurodegenerative Disease Research (JPND) initiative has issued a call for…
January 12, 2023 - 2 minutes
Japanese research offers hope for Fukuyama muscular dystrophy patients
Fukuyama congenital muscular dystrophy (FCMD) is the second most common form of childhood muscular dystrophy…
December 12, 2022 - 4 minutes
Scientists identify genetic variant causing ALS in some patients
Researchers at Nagoya University in Japan have identified a novel genetic variant found in some…
December 7, 2022 - 4 minutes
bit.bio expands portfolio for drug discovery in neurodegenerative and neurological diseases
Cell coding company bit.bio has made three additions to its product portfolio: ioGlutamatergic Neurons MAPT…
November 30, 2022 - 3 minutes
Immune cells in ALS patients can predict the course of the disease
By measuring immune cells in the cerebrospinal fluid when diagnosing ALS, it is possible to…
November 23, 2022 - 2 minutes
FundaMental Pharma launches with €10M to advance first-in-class neuroprotectant
FundaMental Pharma GmbH, a preclinical neuroscience company spun out of Heidelberg University in Germany, has…
November 17, 2022 - 2 minutes
BrainEver and 3P Biopharmaceuticals developing drug with hopes to cure ALS
3P BioPharmaceuticals and BrainEver are to collaborate on developing hEng1, a recombinant homeoprotein, to treat…
November 15, 2022 - 2 minutes
ResQ Biotech is using bacteria to discover Alzheimer’s treatments
Protein misfolding underlies many incurable conditions such as Alzheimer’s disease and amyotrophic lateral sclerosis (ALS).…
November 10, 2022 - 4 minutes
Funding for NRG Therapeutics to work on mitochondria link to Parkinson’s and ALS
NRG Therapeutics, Ltd. has closed a £16 million ($18.2 million) series A financing. The funding…
November 10, 2022 - 3 minutes
Centogene launches rare and neurodegenerative disease Biodata Network
German company, Centogene N.V., today (November 4) announced its launch of Biodata Network, a portfolio…
November 4, 2022 - 3 minutes
Human cells can now help scientists accelerate cure for neurodegenerative diseases
Cell products providing a scalable source of human cells can now help scientists study neurogenerative…
September 29, 2022 - 3 minutes
